Nucleic Acids for Molecular Diagnosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Table of Contents

1 Market Overview
    1.1 Nucleic Acids for Molecular Diagnosis Product Introduction
    1.2 Global Nucleic Acids for Molecular Diagnosis Market Size Forecast (2020-2031)
    1.3 Nucleic Acids for Molecular Diagnosis Market Trends & Drivers
        1.3.1 Nucleic Acids for Molecular Diagnosis Industry Trends
        1.3.2 Nucleic Acids for Molecular Diagnosis Market Drivers & Opportunity
        1.3.3 Nucleic Acids for Molecular Diagnosis Market Challenges
        1.3.4 Nucleic Acids for Molecular Diagnosis Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Competitive Analysis by Company
    2.1 Global Nucleic Acids for Molecular Diagnosis Players Revenue Ranking (2024)
    2.2 Global Nucleic Acids for Molecular Diagnosis Revenue by Company (2020-2025)
    2.3 Key Companies Nucleic Acids for Molecular Diagnosis Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Nucleic Acids for Molecular Diagnosis Product Offered
    2.5 Key Companies Time to Begin Mass Production of Nucleic Acids for Molecular Diagnosis
    2.6 Nucleic Acids for Molecular Diagnosis Market Competitive Analysis
        2.6.1 Nucleic Acids for Molecular Diagnosis Market Concentration Rate (2020-2025)
        2.6.2 Global 5 and 10 Largest Companies by Nucleic Acids for Molecular Diagnosis Revenue in 2024
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acids for Molecular Diagnosis as of 2024)
    2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 DNA Series
        3.1.2 RNA Series
    3.2 Global Nucleic Acids for Molecular Diagnosis Sales Value by Type
        3.2.1 Global Nucleic Acids for Molecular Diagnosis Sales Value by Type (2020 VS 2024 VS 2031)
        3.2.2 Global Nucleic Acids for Molecular Diagnosis Sales Value, by Type (2020-2031)
        3.2.3 Global Nucleic Acids for Molecular Diagnosis Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Infectious Diseases
        4.1.2 Early Cancer Screening
        4.1.3 Blood Screening
        4.1.4 Genetic Diseases
        4.1.5 Genome Sequencing
        4.1.6 Other
    4.2 Global Nucleic Acids for Molecular Diagnosis Sales Value by Application
        4.2.1 Global Nucleic Acids for Molecular Diagnosis Sales Value by Application (2020 VS 2024 VS 2031)
        4.2.2 Global Nucleic Acids for Molecular Diagnosis Sales Value, by Application (2020-2031)
        4.2.3 Global Nucleic Acids for Molecular Diagnosis Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region
    5.1 Global Nucleic Acids for Molecular Diagnosis Sales Value by Region
        5.1.1 Global Nucleic Acids for Molecular Diagnosis Sales Value by Region: 2020 VS 2024 VS 2031
        5.1.2 Global Nucleic Acids for Molecular Diagnosis Sales Value by Region (2020-2025)
        5.1.3 Global Nucleic Acids for Molecular Diagnosis Sales Value by Region (2026-2031)
        5.1.4 Global Nucleic Acids for Molecular Diagnosis Sales Value by Region (%), (2020-2031)
    5.2 North America
        5.2.1 North America Nucleic Acids for Molecular Diagnosis Sales Value, 2020-2031
        5.2.2 North America Nucleic Acids for Molecular Diagnosis Sales Value by Country (%), 2024 VS 2031
    5.3 Europe
        5.3.1 Europe Nucleic Acids for Molecular Diagnosis Sales Value, 2020-2031
        5.3.2 Europe Nucleic Acids for Molecular Diagnosis Sales Value by Country (%), 2024 VS 2031
    5.4 Asia Pacific
        5.4.1 Asia Pacific Nucleic Acids for Molecular Diagnosis Sales Value, 2020-2031
        5.4.2 Asia Pacific Nucleic Acids for Molecular Diagnosis Sales Value by Region (%), 2024 VS 2031
    5.5 South America
        5.5.1 South America Nucleic Acids for Molecular Diagnosis Sales Value, 2020-2031
        5.5.2 South America Nucleic Acids for Molecular Diagnosis Sales Value by Country (%), 2024 VS 2031
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Nucleic Acids for Molecular Diagnosis Sales Value, 2020-2031
        5.6.2 Middle East & Africa Nucleic Acids for Molecular Diagnosis Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Nucleic Acids for Molecular Diagnosis Sales Value Growth Trends, 2020 VS 2024 VS 2031
    6.2 Key Countries/Regions Nucleic Acids for Molecular Diagnosis Sales Value, 2020-2031
    6.3 United States
        6.3.1 United States Nucleic Acids for Molecular Diagnosis Sales Value, 2020-2031
        6.3.2 United States Nucleic Acids for Molecular Diagnosis Sales Value by Type (%), 2024 VS 2031
        6.3.3 United States Nucleic Acids for Molecular Diagnosis Sales Value by Application, 2024 VS 2031
    6.4 Europe
        6.4.1 Europe Nucleic Acids for Molecular Diagnosis Sales Value, 2020-2031
        6.4.2 Europe Nucleic Acids for Molecular Diagnosis Sales Value by Type (%), 2024 VS 2031
        6.4.3 Europe Nucleic Acids for Molecular Diagnosis Sales Value by Application, 2024 VS 2031
    6.5 China
        6.5.1 China Nucleic Acids for Molecular Diagnosis Sales Value, 2020-2031
        6.5.2 China Nucleic Acids for Molecular Diagnosis Sales Value by Type (%), 2024 VS 2031
        6.5.3 China Nucleic Acids for Molecular Diagnosis Sales Value by Application, 2024 VS 2031
    6.6 Japan
        6.6.1 Japan Nucleic Acids for Molecular Diagnosis Sales Value, 2020-2031
        6.6.2 Japan Nucleic Acids for Molecular Diagnosis Sales Value by Type (%), 2024 VS 2031
        6.6.3 Japan Nucleic Acids for Molecular Diagnosis Sales Value by Application, 2024 VS 2031
    6.7 South Korea
        6.7.1 South Korea Nucleic Acids for Molecular Diagnosis Sales Value, 2020-2031
        6.7.2 South Korea Nucleic Acids for Molecular Diagnosis Sales Value by Type (%), 2024 VS 2031
        6.7.3 South Korea Nucleic Acids for Molecular Diagnosis Sales Value by Application, 2024 VS 2031
    6.8 Southeast Asia
        6.8.1 Southeast Asia Nucleic Acids for Molecular Diagnosis Sales Value, 2020-2031
        6.8.2 Southeast Asia Nucleic Acids for Molecular Diagnosis Sales Value by Type (%), 2024 VS 2031
        6.8.3 Southeast Asia Nucleic Acids for Molecular Diagnosis Sales Value by Application, 2024 VS 2031
    6.9 India
        6.9.1 India Nucleic Acids for Molecular Diagnosis Sales Value, 2020-2031
        6.9.2 India Nucleic Acids for Molecular Diagnosis Sales Value by Type (%), 2024 VS 2031
        6.9.3 India Nucleic Acids for Molecular Diagnosis Sales Value by Application, 2024 VS 2031

7 Company Profiles
    7.1 Danaher Corporation
        7.1.1 Danaher Corporation Profile
        7.1.2 Danaher Corporation Main Business
        7.1.3 Danaher Corporation Nucleic Acids for Molecular Diagnosis Products, Services and Solutions
        7.1.4 Danaher Corporation Nucleic Acids for Molecular Diagnosis Revenue (US$ Million) & (2020-2025)
        7.1.5 Danaher Corporation Recent Developments
    7.2 Merck KGaA
        7.2.1 Merck KGaA Profile
        7.2.2 Merck KGaA Main Business
        7.2.3 Merck KGaA Nucleic Acids for Molecular Diagnosis Products, Services and Solutions
        7.2.4 Merck KGaA Nucleic Acids for Molecular Diagnosis Revenue (US$ Million) & (2020-2025)
        7.2.5 Merck KGaA Recent Developments
    7.3 Eurofins Scientific SE
        7.3.1 Eurofins Scientific SE Profile
        7.3.2 Eurofins Scientific SE Main Business
        7.3.3 Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Products, Services and Solutions
        7.3.4 Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Revenue (US$ Million) & (2020-2025)
        7.3.5 Eurofins Scientific SE Recent Developments
    7.4 Thermo Fisher Scientific Inc.
        7.4.1 Thermo Fisher Scientific Inc. Profile
        7.4.2 Thermo Fisher Scientific Inc. Main Business
        7.4.3 Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Products, Services and Solutions
        7.4.4 Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Revenue (US$ Million) & (2020-2025)
        7.4.5 Thermo Fisher Scientific Inc. Recent Developments
    7.5 Agilent Technologies, Inc.
        7.5.1 Agilent Technologies, Inc. Profile
        7.5.2 Agilent Technologies, Inc. Main Business
        7.5.3 Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Products, Services and Solutions
        7.5.4 Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Revenue (US$ Million) & (2020-2025)
        7.5.5 Agilent Technologies, Inc. Recent Developments
    7.6 Kaneka Eurogentec S.A.
        7.6.1 Kaneka Eurogentec S.A. Profile
        7.6.2 Kaneka Eurogentec S.A. Main Business
        7.6.3 Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Products, Services and Solutions
        7.6.4 Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Revenue (US$ Million) & (2020-2025)
        7.6.5 Kaneka Eurogentec S.A. Recent Developments
    7.7 Aji Bio-Pharma
        7.7.1 Aji Bio-Pharma Profile
        7.7.2 Aji Bio-Pharma Main Business
        7.7.3 Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Products, Services and Solutions
        7.7.4 Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Revenue (US$ Million) & (2020-2025)
        7.7.5 Aji Bio-Pharma Recent Developments
    7.8 L.G.C Biosearch Technologies
        7.8.1 L.G.C Biosearch Technologies Profile
        7.8.2 L.G.C Biosearch Technologies Main Business
        7.8.3 L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Products, Services and Solutions
        7.8.4 L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Revenue (US$ Million) & (2020-2025)
        7.8.5 L.G.C Biosearch Technologies Recent Developments
    7.9 Integrated DNA Technologies
        7.9.1 Integrated DNA Technologies Profile
        7.9.2 Integrated DNA Technologies Main Business
        7.9.3 Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Products, Services and Solutions
        7.9.4 Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Revenue (US$ Million) & (2020-2025)
        7.9.5 Integrated DNA Technologies Recent Developments
    7.10 Bio-synthesis Inc.
        7.10.1 Bio-synthesis Inc. Profile
        7.10.2 Bio-synthesis Inc. Main Business
        7.10.3 Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Products, Services and Solutions
        7.10.4 Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Revenue (US$ Million) & (2020-2025)
        7.10.5 Bio-synthesis Inc. Recent Developments
    7.11 metabion
        7.11.1 metabion Profile
        7.11.2 metabion Main Business
        7.11.3 metabion Nucleic Acids for Molecular Diagnosis Products, Services and Solutions
        7.11.4 metabion Nucleic Acids for Molecular Diagnosis Revenue (US$ Million) & (2020-2025)
        7.11.5 metabion Recent Developments
    7.12 QIAGEN
        7.12.1 QIAGEN Profile
        7.12.2 QIAGEN Main Business
        7.12.3 QIAGEN Nucleic Acids for Molecular Diagnosis Products, Services and Solutions
        7.12.4 QIAGEN Nucleic Acids for Molecular Diagnosis Revenue (US$ Million) & (2020-2025)
        7.12.5 QIAGEN Recent Developments
    7.13 Hongene
        7.13.1 Hongene Profile
        7.13.2 Hongene Main Business
        7.13.3 Hongene Nucleic Acids for Molecular Diagnosis Products, Services and Solutions
        7.13.4 Hongene Nucleic Acids for Molecular Diagnosis Revenue (US$ Million) & (2020-2025)
        7.13.5 Hongene Recent Developments
    7.14 Synthgene
        7.14.1 Synthgene Profile
        7.14.2 Synthgene Main Business
        7.14.3 Synthgene Nucleic Acids for Molecular Diagnosis Products, Services and Solutions
        7.14.4 Synthgene Nucleic Acids for Molecular Diagnosis Revenue (US$ Million) & (2020-2025)
        7.14.5 Synthgene Recent Developments

8 Industry Chain Analysis
    8.1 Nucleic Acids for Molecular Diagnosis Industrial Chain
    8.2 Nucleic Acids for Molecular Diagnosis Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Nucleic Acids for Molecular Diagnosis Sales Model
        8.5.2 Sales Channel
        8.5.3 Nucleic Acids for Molecular Diagnosis Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Nucleic Acids for Molecular Diagnosis Market Trends
 Table 2. Nucleic Acids for Molecular Diagnosis Market Drivers & Opportunity
 Table 3. Nucleic Acids for Molecular Diagnosis Market Challenges
 Table 4. Nucleic Acids for Molecular Diagnosis Market Restraints
 Table 5. Global Nucleic Acids for Molecular Diagnosis Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Nucleic Acids for Molecular Diagnosis Revenue Market Share by Company (2020-2025)
 Table 7. Key Companies Nucleic Acids for Molecular Diagnosis Manufacturing Base Distribution and Headquarters
 Table 8. Key Companies Nucleic Acids for Molecular Diagnosis Product Type
 Table 9. Key Companies Time to Begin Mass Production of Nucleic Acids for Molecular Diagnosis
 Table 10. Global Nucleic Acids for Molecular Diagnosis Companies Market Concentration Ratio (CR5 and HHI)
 Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acids for Molecular Diagnosis as of 2024)
 Table 12. Mergers & Acquisitions, Expansion Plans
 Table 13. Global Nucleic Acids for Molecular Diagnosis Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 14. Global Nucleic Acids for Molecular Diagnosis Sales Value by Type (2020-2025) & (US$ Million)
 Table 15. Global Nucleic Acids for Molecular Diagnosis Sales Value by Type (2026-2031) & (US$ Million)
 Table 16. Global Nucleic Acids for Molecular Diagnosis Sales Market Share in Value by Type (2020-2025)
 Table 17. Global Nucleic Acids for Molecular Diagnosis Sales Market Share in Value by Type (2026-2031)
 Table 18. Global Nucleic Acids for Molecular Diagnosis Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 19. Global Nucleic Acids for Molecular Diagnosis Sales Value by Application (2020-2025) & (US$ Million)
 Table 20. Global Nucleic Acids for Molecular Diagnosis Sales Value by Application (2026-2031) & (US$ Million)
 Table 21. Global Nucleic Acids for Molecular Diagnosis Sales Market Share in Value by Application (2020-2025)
 Table 22. Global Nucleic Acids for Molecular Diagnosis Sales Market Share in Value by Application (2026-2031)
 Table 23. Global Nucleic Acids for Molecular Diagnosis Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 24. Global Nucleic Acids for Molecular Diagnosis Sales Value by Region (2020-2025) & (US$ Million)
 Table 25. Global Nucleic Acids for Molecular Diagnosis Sales Value by Region (2026-2031) & (US$ Million)
 Table 26. Global Nucleic Acids for Molecular Diagnosis Sales Value by Region (2020-2025) & (%)
 Table 27. Global Nucleic Acids for Molecular Diagnosis Sales Value by Region (2026-2031) & (%)
 Table 28. Key Countries/Regions Nucleic Acids for Molecular Diagnosis Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 29. Key Countries/Regions Nucleic Acids for Molecular Diagnosis Sales Value, (2020-2025) & (US$ Million)
 Table 30. Key Countries/Regions Nucleic Acids for Molecular Diagnosis Sales Value, (2026-2031) & (US$ Million)
 Table 31. Danaher Corporation Basic Information List
 Table 32. Danaher Corporation Description and Business Overview
 Table 33. Danaher Corporation Nucleic Acids for Molecular Diagnosis Products, Services and Solutions
 Table 34. Revenue (US$ Million) in Nucleic Acids for Molecular Diagnosis Business of Danaher Corporation (2020-2025)
 Table 35. Danaher Corporation Recent Developments
 Table 36. Merck KGaA Basic Information List
 Table 37. Merck KGaA Description and Business Overview
 Table 38. Merck KGaA Nucleic Acids for Molecular Diagnosis Products, Services and Solutions
 Table 39. Revenue (US$ Million) in Nucleic Acids for Molecular Diagnosis Business of Merck KGaA (2020-2025)
 Table 40. Merck KGaA Recent Developments
 Table 41. Eurofins Scientific SE Basic Information List
 Table 42. Eurofins Scientific SE Description and Business Overview
 Table 43. Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Products, Services and Solutions
 Table 44. Revenue (US$ Million) in Nucleic Acids for Molecular Diagnosis Business of Eurofins Scientific SE (2020-2025)
 Table 45. Eurofins Scientific SE Recent Developments
 Table 46. Thermo Fisher Scientific Inc. Basic Information List
 Table 47. Thermo Fisher Scientific Inc. Description and Business Overview
 Table 48. Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Products, Services and Solutions
 Table 49. Revenue (US$ Million) in Nucleic Acids for Molecular Diagnosis Business of Thermo Fisher Scientific Inc. (2020-2025)
 Table 50. Thermo Fisher Scientific Inc. Recent Developments
 Table 51. Agilent Technologies, Inc. Basic Information List
 Table 52. Agilent Technologies, Inc. Description and Business Overview
 Table 53. Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Products, Services and Solutions
 Table 54. Revenue (US$ Million) in Nucleic Acids for Molecular Diagnosis Business of Agilent Technologies, Inc. (2020-2025)
 Table 55. Agilent Technologies, Inc. Recent Developments
 Table 56. Kaneka Eurogentec S.A. Basic Information List
 Table 57. Kaneka Eurogentec S.A. Description and Business Overview
 Table 58. Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Products, Services and Solutions
 Table 59. Revenue (US$ Million) in Nucleic Acids for Molecular Diagnosis Business of Kaneka Eurogentec S.A. (2020-2025)
 Table 60. Kaneka Eurogentec S.A. Recent Developments
 Table 61. Aji Bio-Pharma Basic Information List
 Table 62. Aji Bio-Pharma Description and Business Overview
 Table 63. Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Products, Services and Solutions
 Table 64. Revenue (US$ Million) in Nucleic Acids for Molecular Diagnosis Business of Aji Bio-Pharma (2020-2025)
 Table 65. Aji Bio-Pharma Recent Developments
 Table 66. L.G.C Biosearch Technologies Basic Information List
 Table 67. L.G.C Biosearch Technologies Description and Business Overview
 Table 68. L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Products, Services and Solutions
 Table 69. Revenue (US$ Million) in Nucleic Acids for Molecular Diagnosis Business of L.G.C Biosearch Technologies (2020-2025)
 Table 70. L.G.C Biosearch Technologies Recent Developments
 Table 71. Integrated DNA Technologies Basic Information List
 Table 72. Integrated DNA Technologies Description and Business Overview
 Table 73. Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Products, Services and Solutions
 Table 74. Revenue (US$ Million) in Nucleic Acids for Molecular Diagnosis Business of Integrated DNA Technologies (2020-2025)
 Table 75. Integrated DNA Technologies Recent Developments
 Table 76. Bio-synthesis Inc. Basic Information List
 Table 77. Bio-synthesis Inc. Description and Business Overview
 Table 78. Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Products, Services and Solutions
 Table 79. Revenue (US$ Million) in Nucleic Acids for Molecular Diagnosis Business of Bio-synthesis Inc. (2020-2025)
 Table 80. Bio-synthesis Inc. Recent Developments
 Table 81. metabion Basic Information List
 Table 82. metabion Description and Business Overview
 Table 83. metabion Nucleic Acids for Molecular Diagnosis Products, Services and Solutions
 Table 84. Revenue (US$ Million) in Nucleic Acids for Molecular Diagnosis Business of metabion (2020-2025)
 Table 85. metabion Recent Developments
 Table 86. QIAGEN Basic Information List
 Table 87. QIAGEN Description and Business Overview
 Table 88. QIAGEN Nucleic Acids for Molecular Diagnosis Products, Services and Solutions
 Table 89. Revenue (US$ Million) in Nucleic Acids for Molecular Diagnosis Business of QIAGEN (2020-2025)
 Table 90. QIAGEN Recent Developments
 Table 91. Hongene Basic Information List
 Table 92. Hongene Description and Business Overview
 Table 93. Hongene Nucleic Acids for Molecular Diagnosis Products, Services and Solutions
 Table 94. Revenue (US$ Million) in Nucleic Acids for Molecular Diagnosis Business of Hongene (2020-2025)
 Table 95. Hongene Recent Developments
 Table 96. Synthgene Basic Information List
 Table 97. Synthgene Description and Business Overview
 Table 98. Synthgene Nucleic Acids for Molecular Diagnosis Products, Services and Solutions
 Table 99. Revenue (US$ Million) in Nucleic Acids for Molecular Diagnosis Business of Synthgene (2020-2025)
 Table 100. Synthgene Recent Developments
 Table 101. Key Raw Materials Lists
 Table 102. Raw Materials Key Suppliers Lists
 Table 103. Nucleic Acids for Molecular Diagnosis Downstream Customers
 Table 104. Nucleic Acids for Molecular Diagnosis Distributors List
 Table 105. Research Programs/Design for This Report
 Table 106. Key Data Information from Secondary Sources
 Table 107. Key Data Information from Primary Sources


List of Figures
 Figure 1. Nucleic Acids for Molecular Diagnosis Product Picture
 Figure 2. Global Nucleic Acids for Molecular Diagnosis Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Nucleic Acids for Molecular Diagnosis Sales Value (2020-2031) & (US$ Million)
 Figure 4. Nucleic Acids for Molecular Diagnosis Report Years Considered
 Figure 5. Global Nucleic Acids for Molecular Diagnosis Players Revenue Ranking (2024) & (US$ Million)
 Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Nucleic Acids for Molecular Diagnosis Revenue in 2024
 Figure 7. Nucleic Acids for Molecular Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 8. DNA Series Picture
 Figure 9. RNA Series Picture
 Figure 10. Global Nucleic Acids for Molecular Diagnosis Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 11. Global Nucleic Acids for Molecular Diagnosis Sales Value Market Share by Type, 2024 & 2031
 Figure 12. Product Picture of Infectious Diseases
 Figure 13. Product Picture of Early Cancer Screening
 Figure 14. Product Picture of Blood Screening
 Figure 15. Product Picture of Genetic Diseases
 Figure 16. Product Picture of Genome Sequencing
 Figure 17. Product Picture of Other
 Figure 18. Global Nucleic Acids for Molecular Diagnosis Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 19. Global Nucleic Acids for Molecular Diagnosis Sales Value Market Share by Application, 2024 & 2031
 Figure 20. North America Nucleic Acids for Molecular Diagnosis Sales Value (2020-2031) & (US$ Million)
 Figure 21. North America Nucleic Acids for Molecular Diagnosis Sales Value by Country (%), 2024 VS 2031
 Figure 22. Europe Nucleic Acids for Molecular Diagnosis Sales Value, (2020-2031) & (US$ Million)
 Figure 23. Europe Nucleic Acids for Molecular Diagnosis Sales Value by Country (%), 2024 VS 2031
 Figure 24. Asia Pacific Nucleic Acids for Molecular Diagnosis Sales Value, (2020-2031) & (US$ Million)
 Figure 25. Asia Pacific Nucleic Acids for Molecular Diagnosis Sales Value by Region (%), 2024 VS 2031
 Figure 26. South America Nucleic Acids for Molecular Diagnosis Sales Value, (2020-2031) & (US$ Million)
 Figure 27. South America Nucleic Acids for Molecular Diagnosis Sales Value by Country (%), 2024 VS 2031
 Figure 28. Middle East & Africa Nucleic Acids for Molecular Diagnosis Sales Value, (2020-2031) & (US$ Million)
 Figure 29. Middle East & Africa Nucleic Acids for Molecular Diagnosis Sales Value by Country (%), 2024 VS 2031
 Figure 30. Key Countries/Regions Nucleic Acids for Molecular Diagnosis Sales Value (%), (2020-2031)
 Figure 31. United States Nucleic Acids for Molecular Diagnosis Sales Value, (2020-2031) & (US$ Million)
 Figure 32. United States Nucleic Acids for Molecular Diagnosis Sales Value by Type (%), 2024 VS 2031
 Figure 33. United States Nucleic Acids for Molecular Diagnosis Sales Value by Application (%), 2024 VS 2031
 Figure 34. Europe Nucleic Acids for Molecular Diagnosis Sales Value, (2020-2031) & (US$ Million)
 Figure 35. Europe Nucleic Acids for Molecular Diagnosis Sales Value by Type (%), 2024 VS 2031
 Figure 36. Europe Nucleic Acids for Molecular Diagnosis Sales Value by Application (%), 2024 VS 2031
 Figure 37. China Nucleic Acids for Molecular Diagnosis Sales Value, (2020-2031) & (US$ Million)
 Figure 38. China Nucleic Acids for Molecular Diagnosis Sales Value by Type (%), 2024 VS 2031
 Figure 39. China Nucleic Acids for Molecular Diagnosis Sales Value by Application (%), 2024 VS 2031
 Figure 40. Japan Nucleic Acids for Molecular Diagnosis Sales Value, (2020-2031) & (US$ Million)
 Figure 41. Japan Nucleic Acids for Molecular Diagnosis Sales Value by Type (%), 2024 VS 2031
 Figure 42. Japan Nucleic Acids for Molecular Diagnosis Sales Value by Application (%), 2024 VS 2031
 Figure 43. South Korea Nucleic Acids for Molecular Diagnosis Sales Value, (2020-2031) & (US$ Million)
 Figure 44. South Korea Nucleic Acids for Molecular Diagnosis Sales Value by Type (%), 2024 VS 2031
 Figure 45. South Korea Nucleic Acids for Molecular Diagnosis Sales Value by Application (%), 2024 VS 2031
 Figure 46. Southeast Asia Nucleic Acids for Molecular Diagnosis Sales Value, (2020-2031) & (US$ Million)
 Figure 47. Southeast Asia Nucleic Acids for Molecular Diagnosis Sales Value by Type (%), 2024 VS 2031
 Figure 48. Southeast Asia Nucleic Acids for Molecular Diagnosis Sales Value by Application (%), 2024 VS 2031
 Figure 49. India Nucleic Acids for Molecular Diagnosis Sales Value, (2020-2031) & (US$ Million)
 Figure 50. India Nucleic Acids for Molecular Diagnosis Sales Value by Type (%), 2024 VS 2031
 Figure 51. India Nucleic Acids for Molecular Diagnosis Sales Value by Application (%), 2024 VS 2031
 Figure 52. Nucleic Acids for Molecular Diagnosis Industrial Chain
 Figure 53. Nucleic Acids for Molecular Diagnosis Manufacturing Cost Structure
 Figure 54. Channels of Distribution (Direct Sales, and Distribution)
 Figure 55. Bottom-up and Top-down Approaches for This Report
 Figure 56. Data Triangulation
 Figure 57. Key Executives Interviewed